According to this study, over the next five years the Closed System Drug Transfer Device (CSTD) market will register a 20.0% CAGR in terms of revenue, the global market size will reach $ 1136.8 million by 2025, from $ 547.9 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Closed System Drug Transfer Device (CSTD) business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Closed System Drug Transfer Device (CSTD) market by type, application, key manufacturers and key regions and countries.
This study considers the Closed System Drug Transfer Device (CSTD) value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Closed Vial Access Devices
Closed Syringe Safety Devices
Closed Bag/Line Access Devices
The segment of closed syringe safety holds a comparatively larger share in global market, which accounts for about 35%.
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Clinic
The hospital holds an important share in terms of applications, and accounts for 92% of the market share.
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
BD Medical, Inc
Equashield
Teva Medical Ltd
Corvida Medical
ICU Medical
B. Braun
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Closed System Drug Transfer Device (CSTD) consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Closed System Drug Transfer Device (CSTD) market by identifying its various subsegments.
Focuses on the key global Closed System Drug Transfer Device (CSTD) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Closed System Drug Transfer Device (CSTD) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Closed System Drug Transfer Device (CSTD) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Closed System Drug Transfer Device (CSTD) Consumption 2015-2025
2.1.2 Closed System Drug Transfer Device (CSTD) Consumption CAGR by Region
2.2 Closed System Drug Transfer Device (CSTD) Segment by Type
2.2.1 Closed Vial Access Devices
2.2.2 Closed Syringe Safety Devices
2.2.3 Closed Bag/Line Access Devices
2.3 Closed System Drug Transfer Device (CSTD) Consumption by Type
2.3.1 Global Closed System Drug Transfer Device (CSTD) Consumption Market Share by Type (2015-2020)
2.3.2 Global Closed System Drug Transfer Device (CSTD) Revenue and Market Share by Type (2015-2020)
2.3.3 Global Closed System Drug Transfer Device (CSTD) Sale Price by Type (2015-2020)
2.4 Closed System Drug Transfer Device (CSTD) Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Closed System Drug Transfer Device (CSTD) Consumption by Application
2.5.1 Global Closed System Drug Transfer Device (CSTD) Consumption Market Share by Type (2015-2020)
2.5.2 Global Closed System Drug Transfer Device (CSTD) Value and Market Share by Type (2015-2020)
2.5.3 Global Closed System Drug Transfer Device (CSTD) Sale Price by Type (2015-2020)
3 Global Closed System Drug Transfer Device (CSTD) by Company
3.1 Global Closed System Drug Transfer Device (CSTD) Sales Market Share by Company
3.1.1 Global Closed System Drug Transfer Device (CSTD) Sales by Company (2018-2020)
3.1.2 Global Closed System Drug Transfer Device (CSTD) Sales Market Share by Company (2018-2020)
3.2 Global Closed System Drug Transfer Device (CSTD) Revenue Market Share by Company
3.2.1 Global Closed System Drug Transfer Device (CSTD) Revenue by Company (2018-2020)
3.2.2 Global Closed System Drug Transfer Device (CSTD) Revenue Market Share by Company (2018-2020)
3.3 Global Closed System Drug Transfer Device (CSTD) Sale Price by Company
3.4 Global Closed System Drug Transfer Device (CSTD) Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Closed System Drug Transfer Device (CSTD) Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Closed System Drug Transfer Device (CSTD) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Closed System Drug Transfer Device (CSTD) by Regions
4.1 Closed System Drug Transfer Device (CSTD) by Regions
4.2 Americas Closed System Drug Transfer Device (CSTD) Consumption Growth
4.3 APAC Closed System Drug Transfer Device (CSTD) Consumption Growth
4.4 Europe Closed System Drug Transfer Device (CSTD) Consumption Growth
4.5 Middle East & Africa Closed System Drug Transfer Device (CSTD) Consumption Growth
5 Americas
5.1 Americas Closed System Drug Transfer Device (CSTD) Consumption by Countries
5.1.1 Americas Closed System Drug Transfer Device (CSTD) Consumption by Countries (2015-2020)
5.1.2 Americas Closed System Drug Transfer Device (CSTD) Value by Countries (2015-2020)
5.2 Americas Closed System Drug Transfer Device (CSTD) Consumption by Type
5.3 Americas Closed System Drug Transfer Device (CSTD) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Closed System Drug Transfer Device (CSTD) Consumption by Regions
6.1.1 APAC Closed System Drug Transfer Device (CSTD) Consumption by Regions (2015-2020)
6.1.2 APAC Closed System Drug Transfer Device (CSTD) Value by Regions (2015-2020)
6.2 APAC Closed System Drug Transfer Device (CSTD) Consumption by Type
6.3 APAC Closed System Drug Transfer Device (CSTD) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Closed System Drug Transfer Device (CSTD) by Countries
7.1.1 Europe Closed System Drug Transfer Device (CSTD) Consumption by Countries (2015-2020)
7.1.2 Europe Closed System Drug Transfer Device (CSTD) Value by Countries (2015-2020)
7.2 Europe Closed System Drug Transfer Device (CSTD) Consumption by Type
7.3 Europe Closed System Drug Transfer Device (CSTD) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Closed System Drug Transfer Device (CSTD) by Countries
8.1.1 Middle East & Africa Closed System Drug Transfer Device (CSTD) Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Closed System Drug Transfer Device (CSTD) Value by Countries (2015-2020)
8.2 Middle East & Africa Closed System Drug Transfer Device (CSTD) Consumption by Type
8.3 Middle East & Africa Closed System Drug Transfer Device (CSTD) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Closed System Drug Transfer Device (CSTD) Distributors
10.3 Closed System Drug Transfer Device (CSTD) Customer
11 Global Closed System Drug Transfer Device (CSTD) Market Forecast
11.1 Global Closed System Drug Transfer Device (CSTD) Consumption Forecast (2021-2025)
11.2 Global Closed System Drug Transfer Device (CSTD) Forecast by Regions
11.2.1 Global Closed System Drug Transfer Device (CSTD) Forecast by Regions (2021-2025)
11.2.2 Global Closed System Drug Transfer Device (CSTD) Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Closed System Drug Transfer Device (CSTD) Forecast by Type
11.8 Global Closed System Drug Transfer Device (CSTD) Forecast by Application
12 Key Players Analysis
12.1 BD Medical, Inc
12.1.1 Company Information
12.1.2 Closed System Drug Transfer Device (CSTD) Product Offered
12.1.3 BD Medical, Inc Closed System Drug Transfer Device (CSTD) Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 BD Medical, Inc Latest Developments
12.2 Equashield
12.2.1 Company Information
12.2.2 Closed System Drug Transfer Device (CSTD) Product Offered
12.2.3 Equashield Closed System Drug Transfer Device (CSTD) Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Equashield Latest Developments
12.3 Teva Medical Ltd
12.3.1 Company Information
12.3.2 Closed System Drug Transfer Device (CSTD) Product Offered
12.3.3 Teva Medical Ltd Closed System Drug Transfer Device (CSTD) Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Teva Medical Ltd Latest Developments
12.4 Corvida Medical
12.4.1 Company Information
12.4.2 Closed System Drug Transfer Device (CSTD) Product Offered
12.4.3 Corvida Medical Closed System Drug Transfer Device (CSTD) Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Corvida Medical Latest Developments
12.5 ICU Medical
12.5.1 Company Information
12.5.2 Closed System Drug Transfer Device (CSTD) Product Offered
12.5.3 ICU Medical Closed System Drug Transfer Device (CSTD) Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 ICU Medical Latest Developments
12.6 B. Braun
12.6.1 Company Information
12.6.2 Closed System Drug Transfer Device (CSTD) Product Offered
12.6.3 B. Braun Closed System Drug Transfer Device (CSTD) Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 B. Braun Latest Developments
...
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Closed System Drug Transfer Device (CSTD) Consumption CAGR by Region 2015-2025 ($ Millions)
Tab